Nicoderm cq and Valacyclovir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nicoderm cq (nicotine) and Valacyclovir (valacyclovir hydrochloride). Common drug interactions include chronic kidney disease among females and osteoporosis among males.

The phase IV clinical study analyzes what interactions people have when they take Nicoderm cq and Valacyclovir. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Nicoderm cq?

Nicoderm cq has active ingredients of nicotine. It is often used in quit smoking. eHealthMe is studying from 18,564 Nicoderm cq users. Check the latest studies of Nicoderm cq.

What is Valacyclovir?

Valacyclovir has active ingredients of valacyclovir hydrochloride. It is often used in genital herpes. eHealthMe is studying from 42,108 Valacyclovir users. Check the latest studies of Valacyclovir.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 31, 2026

15 people who take Nicoderm cq and Valacyclovir together, and have interactions are studied.

Nicoderm cq and Valacyclovir drug interactions.

What are the common drug interactions of Nicoderm Cq and Valacyclovir, by gender? *:

female:

  1. Chronic kidney disease
  2. Compartment syndrome (painful condition that occurs when pressure within the muscles builds to dangerous levels)
  3. Device failure
  4. Gait disturbance
  5. Hypoxia (low oxygen in tissues)
  6. Injection site pain
  7. Lymphocyte count decreased
  8. Muscle atrophy (a decrease in the mass of the muscle)
  9. Muscular weakness (muscle weakness)
  10. Oedema (fluid collection in tissue)

male:

  1. Osteoporosis (bones weak and more likely to break)
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Blood creatinine increased
  4. Protein urine present
  5. Rotator cuff syndrome (a spectrum of conditions affecting the rotator cuff tendons of the shoulder)
  6. Tendon rupture (tear of tendon)
  7. Bone disorder
  8. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  9. Constipation
  10. Pneumonia

What are the common drug interactions of Nicoderm Cq and Valacyclovir, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Compartment syndrome (painful condition that occurs when pressure within the muscles builds to dangerous levels)
  2. Device failure
  3. Gait disturbance
  4. Injection site pain
  5. Muscle atrophy (a decrease in the mass of the muscle)
  6. Muscular weakness (muscle weakness)
  7. Oedema (fluid collection in tissue)
  8. Scar
  9. Sensory disturbance (sense disturbance)
  10. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)

60+:

  1. Chronic kidney disease
  2. Hypoxia (low oxygen in tissues)
  3. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  4. Lymphocyte count decreased
  5. Pneumonia
  6. Renal failure (kidney dysfunction)
  7. Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node)
  8. Asthenia (weakness)
  9. Constipation
  10. Dyspepsia (indigestion)

What are the existing conditions these people have? *

  1. Pain: 7 people, 46.67%
  2. High Blood Cholesterol: 6 people, 40.00%
  3. Depression: 6 people, 40.00%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 40.00%
  5. Stress And Anxiety: 5 people, 33.33%
  6. Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 26.67%
  7. Bone Pain: 4 people, 26.67%
  8. Hiv Infection: 4 people, 26.67%
  9. Viral Infection: 4 people, 26.67%
  10. Androgen Deficiency: 4 people, 26.67%

* Approximation only. Some reports may have incomplete information.

Do you take Nicoderm cq and Valacyclovir?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Nicoderm cq and Valacyclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nicoderm cq:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Valacyclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nicoderm cq and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Valacyclovir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on nicotine and valacyclovir hydrochloride (the active ingredients of Nicoderm cq and Valacyclovir, respectively), and Nicoderm cq and Valacyclovir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: